Showing posts with label Psoriasis. Show all posts
Showing posts with label Psoriasis. Show all posts
Tuesday, October 22, 2013

Pfizer reports positive results from two tofacitinib Phase 3 trials for chronic plaque psoriasis

›
In continuation of my update on  Tofacitinib We know that,  Tofacitinib  (trade name  Xeljanz , formerly  tasocitinib ,  CP-690550 ) ...
Wednesday, April 24, 2013

FDA Approves Tecfidera - a New Treatment for Multiple Sclerosis

›
We know that, Dimethyl fumarate  (DMF) is the methyl ester of fumaric acid. DMF was initially recognized as a very effective hypoxic cel...
Monday, August 8, 2011

FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

›
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
Monday, December 21, 2009

Apremilast a new hope for severe Psoriasis...

›
About apremilast : (S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonyl- ethyl]- 1,3-dioxo - 2,3 -dihydro - 1H-isoindol-4-yl}acetamide. ...
Wednesday, December 2, 2009

Positive data from rose bengal disodium for psoriasis & atopic dermatitis....

›
Acid Red 94, (Rose Bengal sodium salt), 3,4,5,6-tetrachloro-2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate : Provectus Pharmaceutic...
Saturday, September 26, 2009

Stelara approved by the FDA for treating psoriasis

›
We know that Stelara (Ustekinumab), is a human monoclonal antibody that binds to the shared p40 protein subunit of human IL-12 and IL-23 wit...